Solara Active Pharma Sciences Limited has informed the exchange regarding the submission of Annual Secretarial Compliance Report for the fInancial year ended March 31, 2026

Solara Active Pharma Sciences has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, as mandated under SEBI Regulation 24A. The report was prepared by Ms. Parimala Natarajan, a Practicing Company Secretary. The secretarial audit covered compliance with multiple SEBI regulations including LODR 2015, ICDR 2018, SAST 2011, SBEB & Sweat Equity Regulations 2021, PIT Regulations 2015, and Depositories Regulations 2018. The auditor has reported full compliance across all 13 checkpoints with no deviations, observations, or penalties. Secretarial standards, policy adoptions, website disclosures, board processes, related party transactions, and insider trading norms all met regulatory requirements. No actions were taken by SEBI or stock exchanges during the review period.